Showing 2051-2060 of 8649 results for "".
- Belkin Vision's Automated, Non-Contact Glaucoma Laser Treatment Receives CE Markhttps://modernod.com/news/belkin-visions-eagle-receives-ce-mark-under-mdr/2480859/Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe. The CE Mark was granted under Medical Device Regulation (MDR) from its notified body DEKRA.
- Kala Pharmaceuticals Launches Its First Direct-to-Consumer Campaign to Increase Awareness of Dry Eye Flareshttps://modernod.com/news/kala-pharmaceuticals-launches-its-first-direct-to-consumer-campaign-to-increase-awareness-of-dry-eye-flares/2480850/Kala Pharmaceuticals, Inc. today announced the launch of its first direct-to-consumer (DTC) campaign, “There for the Flare.” The campaign leverages digital channels to educate patients about dry eye flares and EYSUVIS® (loteprednol etabonate ophthalmic suspension 0.25%) and encour
- Zeiss Offers New SLT Application for the Visulas Green Therapeutic Laserhttps://modernod.com/news/zeiss-offers-new-slt-application-for-the-visulas-green-therapeutic-laser/2480842/Zeiss Medical Technology announced that it now offers the new SLT add-on to its Visulas green laser, part of an integrated glaucoma workflow designed to advance safe and effective glaucoma treatment. The new SLT laser feature offers unique protocols that may im
- Bausch + Lomb Announces Launch of IPOhttps://modernod.com/news/bausch-lomb-announces-launch-of-ipo/2480816/Bausch + Lomb announced the launch of its initial public offering (IPO) and the commencement of the roadshow for the IPO. Bausch + Lomb, which is being spun out of Bausch Health, plan to sell 35 million common shares for $21 to $24 per share, for a valuation of as much $8.4 billion
- Haag-Streit Launches the Eyestar 900 Anterior Chamber Suitehttps://modernod.com/news/haag-streit-launches-the-eyestar-900-anterior-chamber-suite/2480794/Haag-Streit has announced the launch of the Eyestar 900 Anterior Chamber Suite (AC-Suite) to compliment the Cataract Suite. The AC-Suite is designed to meet the growing demand for improved outcomes in cataract and refractive surgery. The Eyestar 900 is based on swep
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack Advancehttps://modernod.com/news/nova-eye-medical-launches-next-generation-canaloplasty-device-for-glaucoma-itrack-advance/2480774/Nova Eye Medical announced the launch of its next generation canaloplasty device, iTrack Advance, in select markets in Europe and the Asia Pacific. The iTrack Advance features the proprietary illuminated fiber optic tip of the original iTrack device, which all
- Bausch + Lomb and Clearside Biomedical Announce US Commercial Launch of Xiperehttps://modernod.com/news/bausch-lomb-and-clearside-biomedical-announce-us-commercial-launch-of-xipere/2480725/Bausch + Lomb announced the US commercial launch of Xipere (triamcinolone acetonide injectable suspension), the first and only therapy approved by the FDA for suprachoroidal use for the treatment of macular edema associated with uveitis. "Xipere is the first and
- New Multi-Language Options Now Available on Reichert.comhttps://modernod.com/news/new-multi-language-options-now-available-on-reichertcom/2480719/Reichert Technologies, a business unit of Ametek, has announced that Reichert.com is now available in five new language options: Chinese, French, German, Italian, and Spanish. Putting customers first will always be Reichert’s main focus. This new capability will help make the information on
- Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officerhttps://modernod.com/news/aerie-pharmaceuticals-appoints-peter-lang-as-chief-financial-officer/2480707/Aerie Pharmaceuticals announced that Peter F. Lang will join the company as Chief Financial Officer, effective March 18, 2022. He will report to Raj Kannan, Chief Executive Officer of Aerie Pharmaceuticals, and become a member of the Aerie Executive Committee.
- Alcon Launches Clareon IOL Portfolio in the UShttps://modernod.com/news/alcon-launches-clareon-iol-portfolio-in-the-us/2480677/Alcon announced the launch of the Clareon family of IOLs in the United States. Utilizing an advanced IOL material, Clareon is designed to deliver consistent visual outcomes and clarity that lasts.[1-7] The Clareon clarity is born out of a glistening-free IOL material that has among